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Abstract The effect of TNF-α on cell death in rat fetal brown 
adipocytes maintained in primary culture was determined. TNF-
oc inhibited proliferation and induced apoptosis in these cells. 
Most of the cells undergoing apoptosis after TNF-α treatment 
did not express PCNA, suggesting an induction of apoptosis by 
TNF-α in non-proliferative cells. IGF-I but not EGF prevented 
TNF-a-induced apoptosis. 
© 1997 Federation of European Biochemical Societies. 
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adipocytic differentiation is essentially regulated as in white 
adipose tissue, it is likely to think about similar mechanisms 
for loss of both adipose tissues. Thus, TNF-oc might be a 
negative regulator of this tissue by different mechanisms 
such as inhibition of differentiation as in white adipocytes 
[11-13] and/or induction of apoptosis. 
In this paper, we present evidences demonstrating that 
TNF-oc induces apoptosis and inhibits cell growth in brown 
adipocytes. IGF-I, but not EGF, rescues from TNF-a-in-
duced apoptosis. 
1. Introduction 
Apoptosis is a specific process of cell elimination in normal 
tissues, considered as an important physiological mechanism 
for regulation of proliferation, development and oncogenesis 
(see [1] for review). 
Little is known, for adipose tissue, about the process of 
adipocyte loss. A regression of adipose tissue in diabetic rats 
[2] and processes of 'dedifferentiation' in vitro [3] have been 
described. Moreover, a dramatic loss of adipose tissue is ob-
served in some diseases such as cancer and severe infection, 
that can render cachexia. Adipocyte apoptosis was demon-
strated to occur in patients with malignancy [4] and in vitro, 
in human adipocytes after growth factor deprivation or mild 
heat injury [5]. Therefore, the loss of adipocytes in certain 
diseases might be a consequence of the induction of apoptosis. 
TNF-oc induces apoptosis in different cell types [6-10]. High 
levels of TNF-oc and other cytokines are produced in obesity 
and in malignancy. TNF-oc has different effects on adipose 
tissue including inhibition of differentiation and induction of 
dedifferentiation in mature adipocytes [11-13]. Therefore, it 
induces a decrease in the number and/or in the size of mature 
adipocytes by these mechanisms. However, a direct role for 
TNF-oc inducing apoptosis in white adipose tissue, as a mech-
anism to eliminate adipocytes, remains unexplored. 
In brown adipose tissue, no process of apoptosis has been 
described. Brown adipose tissue produces heat by a mecha-
nism called 'non-shivering thermogenesis'. This tissue is active 
in newborn mammals, in animals exposed to cold, in arousal 
from hibernation and after diet-induction [14]. Noradrenaline 
[15], T3 [16,17], IGF-I [18-20] and insulin [20] are positive 
regulators of this tissue. IGF-I [18-20] and insulin [20] induce 
its differentiation in fetal brown adipocytes in culture as in 
white adipocytes [21,22]. However, the signals involved in the 
negative regulation of the tissue and in the inactivation or 
involution of this tissue are not yet clear. For example, after 
the neonatal period it is not known which signals determine 
the inactivation and/or disappearance of the tissue. Since the 
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2. Materials and methods 
2.1. Isolation of fetal brown adipocytes and culture 
Fetal brown adipocytes from 20 day old rat fetuses were isolated as 
described (15) and maintained in primary cultures. Cells were grown 
in minimum essential medium (MEM) supplemented with 10% fetal 
calf serum (FCS) for 24 h. Then, cells were serum starved o/n and 
maintained in the absence or in the presence of TNF-oc (1-10 ng/ml), 
IGF-I (2.5 nM), EGF (20 ng/ml), IGF-I plus TNF-oc or EGF plus 
TNF-a for 24 h, 32 h, 48 h. 
2.2. Flow cytometric analysis 
Analysis of DNA content, cell cycle and PCNA content of the cells 
in the different phases of the cell cycle was performed in a FACScan 
flow cytometer (Becton-Dickinson, San José, CA). DNA was stained 
with propidium iodide (PI) using the Bio-Rad reagent kit (Kinesis 50, 
#470-0023), following the manufacturer's protocol. When PCNA con-
tent was analyzed in parallel to the cellular DNA content, the Bio-
Rad reagent kit containing PI and an anti-PCNA antibody (PCNA/ 
Kinesis 50, #470-0043) was used. Measurements were carried out us-
ing a Double Discriminator Module in order to discriminate doublets. 
10000 cells were acquired per sample. Then, the percentage of cells 
with DNA content lower than 2C was calculated as well as the per-
centage of cells in the G0/G1, S and G2/M phases of the cell cycle, 
using Multicycle software (Phoenix software). When PCNA and cel-
lular DNA content were simultaneously analyzed, the percentage of 
cells expressing PCNA with different DNA contents was also calcu-
lated using CellQuest software (Becton-Dickinson). 
The presence of phosphatidylserine in the outer layer of the plasma 
membrane (an early feature of apoptosis) from control and TNF-a 
treated brown adipocytes, was detected by specific binding to annexin-
V using the Annexin-V-Fluos kit from Boehringer Mannheim (cat. no. 
1828681). Cells were incubated with propidium iodide and/or annexin-
V-Fluorescence and analyzed by flow cytometry. The percentage of 
cells positive for annexin-V, considered as apoptotic, and those pos-
itive for annexin-V and propidium iodide, considered as necrotic, was 
determined. 
2.3. Analysis of DNA fragmentation 
DNA fragmentation was determined by a modified version [23] of 
the method of Lyons [24]. After scrapping, brown adipocytes were 
resuspended in a buffer containing 10 mM EDTA, 0.25% Triton X-
100, 2.5 mM Tris-HCl, pH 8.0 and maintained at 4°C for 15 min. 
Intact nuclei were pelleted and eliminated by centrifugation at 500 Xg 
for 10 min and the supernatant centrifuged at 25 000Xg at 4°C for 30 
min. DNA from the supernatant was precipitated with ethanol at 
—80°C, pelleted by microcentrifugation at 4°C for 15 min, dried 
and resuspended in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0 (TE 
buffer). Then, it was incubated with 0.1 mg/ml RNase A for 30 min 
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at 37°C and with 0.25 mg/ml proteinase К for 2-3 h at 37°C to 
eliminate RNA and proteins. DNA was purified by phenol-chloro-
form extraction, precipitated with ethanol at —80°C, and resuspended 
in ТЕ buffer. Then, DNA was electrophoresed in a 1.5% agarose gel. 
2.4. Confocal microscopy analysis 
Morphology of chromatin from apoptotic and intact nuclei was 
detected by confocal microscopy analysis of brown adipocytes at-
tached to plates, incubated for 10 min with propidium iodide 
(0.005%) (PI) and SYTO 13 in PBS. Only necrotic cells and lately 
apoptotic cells can be labeled by PI, since PI only goes into cells that 
loose their plasma membrane integrity. SYTO 13 labels all nuclei. 
Thus, using this method, we can distinguish between intact nuclei 
and necrotic/apoptotic nuclei. MRC 1000 confocal microscopy (Bio-
Rad, Hempstead, UK) was used and digital images were printed using 
Lasergraphics. 
3. Results and discussion 
3.1. TNF-a inhibits proliferation in rat fetal brown adipocytes 
Proliferation, differentiation and apoptosis are necessary 
processes for development [1,25]. Sometimes, signals that in-
hibit proliferation in a certain cell type, are also capable to 
induce apoptosis in order to remove the excess of cells [25] 
under certain circumstances. 
To study the effect of TNF-a on the cell cycle, the flow 
cytometric analysis of cellular DNA stained with propidium 
iodide was used. The percentage of cells in the different phases 
of the cell cycle was calculated and it is shown in Table 1. 
Brown adipocytes untreated or treated for 24 h with TNF-a, 
IGF-I (the best mitogen for these cells) or IGF-I plus TNF-a 
were studied to assess the role of TNF-a on basal (control) 
and IGF-I-induced cell growth. TNF-a induced a significant 
decrease (P < 0.05) in the percentage of cells in the S phase of 
the cell cycle as compared with untreated cells (control). IGF-
I, which is a potent mitogen for these cells [18], produced a 
significant (P < 0.05) increase in the percentage of cells in the 
S phase as well as in the percentage of cells in the G2/M 
phases (P<0.01) of the cell cycle. When cells were treated 
with IGF-I plus TNF-a, the IGF-I-induced mitogenic effect 
was completely abolished. Thus, a significant (P<0.01) de-
crease in the percentage of cells in the S phase was observed as 
well as in the percentage of cells in the G2/M phases 
(P < 0.05) of the cell cycle when compared with IGF-I treated 
cells. Therefore, TNF-a was able to inhibit the endogenous 
and the IGF-I-induced cell growth in fetal brown adipocytes. 
So, the next step was to determine whether TNF-a, besides 
inhibiting proliferation, would be able to induce apoptosis in 
brown adipocytes. 
Fig. 1. Effect of TNF-a on cellular DNA content, DNA fragmenta-
tion, nuclei morphology and plasma membrane annexin-V-FITC la-
beling. A: DNA content histograms from flow cytometric measure-
ments in brown adipocytes untreated (C) or treated with 10 ng/ml 
TNF-a for 48 h. Ml bar represents cells with a DNA content lower 
than 2C, being 7.09 ± 1.03 for control cells and 22 ±0.80 for TNF-a 
treated cells. B: Representative DNA ladder. Cytoplasmic DNA 
from brown adipocytes untreated (C) or treated with 10 ng/ml 
TNF-a (T) for 48 h was extracted and analyzed as described under 
Section 2; M, molecular weight markers (100 bp ladder DNA). C: 
Confocal microscopy analysis of nuclear morphology in brown adi-
pocytes treated with 10 ng/ml TNF-a for 48 h after staining with 
propidium iodide (PI) and SYTO 13. Head arrows show intact nu-
clei stained by SYTO 13 and arrows show apoptotic bodies and 
fragmented nuclei stained by PI. D: Flow cytometric analysis in 
brown adipocytes untreated (Control) and treated with 10 ng/ml 
TNF-a (TNF-a) for 48 h after labeling with annexin-V. 
3.2. Characterization of the TNF-a-induced apoptotic cell 
death in rat fetal brown adipocytes. Relation between 
PCNA expression and TNF-a-induced apoptosis 
Rat fetal brown adipocytes were maintained in primary 
culture in the absence of serum, untreated or treated with 
TNF-a for 24 h, 32 h or 48 h, and the effect of TNF-a on 
cell death was studied. TNF-a began to induce certain mor-
phological changes after 24-32 h, being more visible after 48 h. 
Table 1 
TNF-a inhibits endogenous and IGF-I-induced proliferation in brown adipocytes 
Treatment G0+G1 phases S phase G2/M phases 
Control 
TNF-a 
IGF-I 
IGF-I+TNF-a 
92.06 ±0.45 
94.75 ±0.41" 
88.43 ±1.25" 
92.83 ±0.58c 
5.30 ±0.41 
3.14 ±0.20" 
7.33 ± 0.90" 
4.53 ± 0.45d 
2.50 ±0.19 
1.99 ±0.33 
3.57±0.33b 
2.63 ± 0.13C 
Cell cycle study was performed by flow cytometry using propidium iodide for DNA staining as described under Section 2. Cells were serum starved 
o/n and maintained for 24 h in the absence of serum untreated (control) or treated either with TNF-a, IGF-I or IGF-I+TNF-a, before the analysis. 
Results are expressed as percentages of cells in the G0+G1, S and G2/M phases of the cell cycle. Statistical analysis was carried out by the Student's 
/-test by comparing with control values "/>< 0.05 and bP==0.01 or with values after IGF-I treatment СР£0.05 and άΡ<0.01. 
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Cells lost cellular contacts, presented cellular blebbing and 
finally, they detached from the plate (data not shown). All 
these changes in the cellular morphology resembled those oc-
curring in an apoptotic cell death process. To assess whether 
TNF-a treated brown adipocytes were dying by a process of 
apoptosis, their DNA content by flow cytometry after staining 
with propidium iodide was first analyzed. Peaks of cells pre-
senting a DNA content lower than 2C after 48 h are shown in 
Fig. 1A, labeled by the Ml bars. Cells treated with TNF-a (10 
ng/ml) for 48 h showed 20-23% of cells with DNA content 
lower than 2C, while untreated cells only showed 5-9%. These 
data pointed out that a percentage of TNF-a treated cells, 
higher than in control cells, could be dying by a process of 
apoptosis. Previously, a complete dose-response study was 
carried out using this cytometric technique. TNF-a induced 
a dose-dependent (1-10 ng/ml) increase in the percentage of 
cells with DNA content lower than 2C, reaching maximal 
levels with 5-10 ng/ml (data not shown). Thus, we used 10 
ng/ml for further analysis. A complete time-course study was 
also done and a gradual increase in the number of cells with 
DNA content lower than 2C was produced in a time-depend-
ent manner, being 15% at 24 h and 22% at 48 h. 
To confirm that TNF-a was inducing a process of apopto-
sis, we used some other methods : analysis of the presence of 
fragmented DNA in the cytoplasmic fraction by electropho-
resis on agarose gels, the presence of apoptotic nuclei by con-
focal microscopy and the presence of phosphatidylserine res-
idues in the outer plasma membrane by flow cytometry after 
binding to annexin-V and staining with propidium iodide 
[26,27]. 
The study of the extranuclear DNA in cells untreated or 
treated with TNF-a for 48 h revealed an induction of DNA 
fragmentation by the TNF-a treatment as shown in Fig. IB. 
DNA from TNF-a treated cells presented different low mo-
lecular weight DNA fragments like a 'ladder' that were not 
present in control cells. The presence of these DNA fragments 
is usually associated with the cleavage of genomic DNA oc-
curring in cells undergoing late apoptosis. 
The analysis of nuclei by confocal microscopy after staining 
with propidium iodide and SYTO 13 showed the presence of a 
higher number of condensed and/or fragmented nuclei in cells 
treated with TNF-a for 48 h than in control cells as it occurs 
in apoptotic cells. In Fig. 1С, a confocal image of nuclei from 
TNF-a treated cells is shown, where apoptotic bodies and 
fragmented nuclei, generated by DNA cleavage, are clearly 
visible. 
Phosphatidylserine is only present in the inner layer of the 
plasma membrane in normal living cells, while in necrotic and 
apoptotic cells it is also present in the outer layer and can be 
bound to annexin-V. Necrotic cells have a plasma membrane 
totally permeable to propidium iodide, meanwhile apoptotic 
cells are less permeable, even negative. Thus, using this flow 
cytometry multiparameter assay, we can distinguish between 
the necrotic cells that are positive for annexin-V and propi-
dium iodide and the apoptotic cells that are positive for an-
nexin-V and negative or low positive for propidium iodide. 
TNF-a treated brown adipocytes showed a higher percentage 
of annexin-V positive cells than control brown adipocytes 
(Fig. ID). All these evidences listed before demonstrated a 
TNF-a-induced apoptosis occurring in brown adipocytes. 
TNF-a is also known to induce apoptosis in other cell types 
[6-10], though in most of the cases, an inhibition of protein 
synthesis is required. In our cell system, this was not neces-
sary. 
Since we have already demonstrated that TNF-a induces 
apoptosis and inhibits cell proliferation (basal and IGF-I-in-
duced) in rat fetal brown adipocytes in primary culture, TNF-
α might be blocking the progression through the cell cycle of 
a percentage of cells and as a consequence these cells would be 
committed to apoptosis. Thus, cells treated with TNF-a 
would be arrested in G0/G1, would not be able to enter 
into the cell cycle and would undergo apoptosis. To prove 
this hypothesis, we measured simultaneously by flow cytom-
etry DNA content and expression of PCNA, the δ subunit of 
DNA polymerase, that is maximally expressed during the S 
phase. This could allow us to know whether PCNA is ex-
pressed in cells which DNA content was lower than 2C, 
that were demonstrated to be apoptotic. 
Table 2 shows the total percentage of cells with DNA con-
tent lower than 2C (apoptotic cells) and the percentage of 
these cells detected either as positive (PCNA positive) or neg-
ative (PCNA negative) for PCNA expression based on their 
ability to bind to an anti-PCNA antibody. These data were 
derived from the cytometric dual parameter analysis of DNA 
and PCNA contents carried out as shown in Fig. 2 for control 
and TNF-a treated cells. Under control conditions, the per-
centages of apoptotic cells PCNA positive and PCNA nega-
tive were similar (Table 2). IGF-I treated cells showed no 
changes in relation to control values. However, TNF-a 
treated cells presented an increase in the percentage of apop-
totic cells, the percentage of these cells that were PCNA neg-
ative being much higher. Thus, these results show that the 
majority of TNF-a treated cells committed to programmed 
cell death do not express PCNA, and, therefore, they are 
Table 2 
TNF-a induces apoptosis in PCNA negative brown adipocytes 
Percentage of cells with DNA content lower than 2C 
Treatment 
Control 
TNF-a 
IGF-I 
IGF-I+TNF-a 
PCNA negative 
3.64 ±1.09 
13.49 ±3.49a 
3.86 ±0.47 
8.10±1.60c 
PCNA positive 
3.43 ±0.26 
7.41 ±2.40 
2.78 ± 0.44 
5.41 ±1.86 
Total 
7.07 ±1.07 
20.14±2.7b 
6.64 ±0.55 
13.51 ±3.4d 
Flow cytometric DNA and PCNA content quantitations analyzed as shown in Fig. 2. Serum starved brown adipocytes were maintained for 48 h 
untreated (control) or treated either with TNF-a, IGF-I or IGF-I+TNF-a, before the analysis. Results are expressed as the percentage of cells with 
DNA content lower than 2C (apoptotic cells) with no detectable PCNA expression (PCNA negative) or detectable PCNA expression (PCNA 
positive) as estimated by their binding to an anti-PCNA antibody. Results are means ± S.E.M. of three separate experiments. Statistical analysis 
was carried out by the Student's i-test by comparing with control values a.P£0.05, ЬР£0.01 or with values after TNF-a treatment СР£0.05, 
dP<0.01. 
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not proliferating. This effect of TNF-a was partially abolished 
when IGF-I was also present. Therefore, these results indicate 
that TNF-oc inhibits proliferation of brown adipocytes and as 
a consequence, the progression through the cell cycle of a 
certain number of cells is blocked and these cells undergo 
apoptosis. 
3.3. IGF-I but not EGF prevents the TNF-a-induced apoptosis 
in rat fetal brown adipocytes maintained in primary culture 
IGF-I is a potent mitogen for brown adipocytes that also 
induces their differentiation [18]. EGF has also a mitogenic 
effect on brown adipocytes. Since in many cell types, apopto-
sis is prevented by the presence of mitogens that allow cells to 
progress through the cell cycle, we checked for this possibility 
in brown adipocytes. 
Once we have demonstrated by several techniques that 
brown adipocytes suffered TNF-a-induced apoptosis and 
that cells with DNA content lower than 2C were actually 
dying by a process of apoptosis, we used the flow cytometric 
analysis of the cell cycle to quantitate apoptotic percentages 
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Fig. 3. IGF-I but not EGF prevents TNF-a-induced decrease in 
DNA content in brown adipocytes. DNA content histograms from 
flow cytometric measurements in brown adipocytes untreated (C) or 
treated for 48 h with TNF-a, IGF-I, IGF-I+TNF-a, EGF or 
EGF+TNF-a carried out as described under Section 2. Ml bar rep-
resents the percentage of cells with a DNA content lower than 2C. 
This percentage was determined and mean values ± S.E.M. of three 
separate experiments are represented in each histogram. 
Fig. 2. TNF-a induces apoptosis in PCNA negative brown adipo-
cytes. A and B: Representative flow cytometric dual parameter 
analysis of DNA and PCNA contents in brown adipocytes un-
treated (A) and treated with 10 ng/ml TNF-a (B) for 48 h. DNA 
(FL3-A, abcises) and PCNA (FL1-H, ordinates) contents were si-
moultaneously analyzed by flow cytometry after cells were stained 
with propidium iodide and labeled with an anti-PCNA antibody as 
described under Section 2. C: Representative PCNA histograms 
from cells inside Rl area, from A and В histograms. These cells 
have a DNA content lower than 2C. Ml bar represents PCNA pos-
itive cells. 
and to assess the effect of IGF-I and EGF on TNF-a-induced 
apoptosis in rat fetal brown adipocytes. 
As it is shown in Fig. 3, brown adipocytes treated with 
TNF-a for 48 h presented 20-23% of cells with DNA content 
lower than 2C, in contrast to the 5-9% observed in control 
cells. IGF-I treated cells presented similar values to those 
from control cells (6-8%). When cells were treated with 
IGF-I and TNF-a, the percentage of cells with DNA content 
lower than 2C was significantly diminished to 12-15% when 
compared to TNF-a treated cells (P<0.01). In contrast, EGF 
was not able to decrease the percentage of cells with DNA 
content lower than 2C or even increased it up to 22-36% 
(EGF+TNF-a). EGF treated cells also presented a higher 
value of apoptotic cells than control cells (8-14%). 
Based on these results, IGF-I prevented the apoptotic cell 
death induced by TNF-a in fetal brown adipocytes in a spe-
cific way, since EGF was not able to do it or even enhanced it. 
Similarly, IGF-I prevented the TNF-a-induced apoptosis in 
p6 and BALB/c 3T3 cells [9], while PDGF or EGF did not. 
IGF-I also maintained the viability of different cell types [28-
31], where the process of apoptosis was induced by other 
means. However, IGF-I did not block the apoptosis process 
in all the cells at 48 h as it has been observed for other 
survival factors in other cell types [23,29]. 
The different effects of IGF-I and EGF on the TNF-a-in-
duced apoptosis in brown adipocytes could be explained by 
the activation of different signaling pathways by these two 
growth factors. Thus, it is likely to think that though some 
of the signaling pathways may be common to both signals, 
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some others may be different [29] and the overall balance of 
them might determine the putative antiapoptotic effect. 
In summary, we have described here for the first time, a 
process of apoptosis occurring in brown adipocytes main-
tained in primary culture. This process is induced by TNF-cc 
and is prevented by IGF-I , but not by E G F . Thus, T N F - a 
might be a mechanism to eliminate brown adipocytes during 
development by the induction of apoptosis. IGF-I , which in-
duces cell growth and differentiation in rat fetal brown adi-
pocytes [18], would maintain cell viability under these circum-
stances. 
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